Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Rizzi

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Leukemia|June 29, 2021
Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19Giuseppe Gritti, Federico Raimondi, Barbara Bottazzi, et al.
Panminerva Medica|February 22, 2022
Frequency, characteristics, and outcome of patients with COVID-19 pneumonia and "silent hypoxemia" at admission: a severity-matched analysisLuca Novelli, Federico Raimondi, Arianna Ghirardi, et al.
Respiratory Medicine and Research|December 6, 2022
One-year mortality in COVID-19 is associated with patients' comorbidities rather than pneumonia severityLuca Novelli, Federico Raimondi, Greta Carioli, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 8, 2025
Real-world use of cefiderocol as monotherapy or combination therapy for the treatment of Gram-negative bacterial infections: the multicentre retrospective CEFI-BAC studyMatteo Augello, Francesca Di Bartolomeo, Benedetta Varisco, et al.
BMC Pulmonary Medicine|March 21, 2021
Covid-19 and gender: lower rate but same mortality of severe disease in women-an observational studyFederico Raimondi, Luca Novelli, Arianna Ghirardi, et al.
Infection Prevention in Practice|December 18, 2024
Use of ICD-9-CM coding for identifying antibiotic prescriptions during hospitalization: a Delphi consensus modelAgnese Comelli, Camilla Genovese, Giulia Renisi, et al.
Heliyon|September 9, 2024
Monoclonal antibodies against SARS-CoV-2 to prevent COVID-19 worsening in a large multicenter cohortAlessandro Soria, Francesca Graziano, Giulia Ghilardi, et al.
Panminerva Medica|November 27, 2020
At the peak of COVID-19 age and disease severity but not comorbidities are predictors of mortality: COVID-19 burden in Bergamo, ItalyLuca Novelli, Federico Raimondi, Arianna Ghirardi, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 22, 2020
Efficacy of β-lactam/β-lactamase inhibitors to treat extended-spectrum beta-lactamase-producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT-SOT Project)Ligia C Pierrotti, Elena Pérez-Nadales, Mario Fernández-Ruiz, et al.
Antimicrobial Agents and Chemotherapy|August 9, 2021
Propensity Score and Desirability of Outcome Ranking Analysis of Ertapenem for Treatment of Nonsevere Bacteremic Urinary Tract Infections Due to Extended-Spectrum-Beta-Lactamase-Producing <i>Enterobacterales</i> in Kidney Transplant RecipientsBelén Gutiérrez-Gutiérrez, Elena Pérez-Nadales, Salvador Pérez-Galera, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Leukemia|June 29, 2021
Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19Giuseppe Gritti, Federico Raimondi, Barbara Bottazzi, et al.
Panminerva Medica|February 22, 2022
Frequency, characteristics, and outcome of patients with COVID-19 pneumonia and "silent hypoxemia" at admission: a severity-matched analysisLuca Novelli, Federico Raimondi, Arianna Ghirardi, et al.
Respiratory Medicine and Research|December 6, 2022
One-year mortality in COVID-19 is associated with patients' comorbidities rather than pneumonia severityLuca Novelli, Federico Raimondi, Greta Carioli, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 8, 2025
Real-world use of cefiderocol as monotherapy or combination therapy for the treatment of Gram-negative bacterial infections: the multicentre retrospective CEFI-BAC studyMatteo Augello, Francesca Di Bartolomeo, Benedetta Varisco, et al.
BMC Pulmonary Medicine|March 21, 2021
Covid-19 and gender: lower rate but same mortality of severe disease in women-an observational studyFederico Raimondi, Luca Novelli, Arianna Ghirardi, et al.
Infection Prevention in Practice|December 18, 2024
Use of ICD-9-CM coding for identifying antibiotic prescriptions during hospitalization: a Delphi consensus modelAgnese Comelli, Camilla Genovese, Giulia Renisi, et al.
Heliyon|September 9, 2024
Monoclonal antibodies against SARS-CoV-2 to prevent COVID-19 worsening in a large multicenter cohortAlessandro Soria, Francesca Graziano, Giulia Ghilardi, et al.
Panminerva Medica|November 27, 2020
At the peak of COVID-19 age and disease severity but not comorbidities are predictors of mortality: COVID-19 burden in Bergamo, ItalyLuca Novelli, Federico Raimondi, Arianna Ghirardi, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 22, 2020
Efficacy of β-lactam/β-lactamase inhibitors to treat extended-spectrum beta-lactamase-producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT-SOT Project)Ligia C Pierrotti, Elena Pérez-Nadales, Mario Fernández-Ruiz, et al.
Antimicrobial Agents and Chemotherapy|August 9, 2021
Propensity Score and Desirability of Outcome Ranking Analysis of Ertapenem for Treatment of Nonsevere Bacteremic Urinary Tract Infections Due to Extended-Spectrum-Beta-Lactamase-Producing <i>Enterobacterales</i> in Kidney Transplant RecipientsBelén Gutiérrez-Gutiérrez, Elena Pérez-Nadales, Salvador Pérez-Galera, et al.
Pageof 9